v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
Shareholders' equity
IPO
Shareholders' equity
Private placement
Shareholders' equity
Ordinary shares
Common Class A
IPO
Ordinary shares
Common Class A
Private placement
Ordinary shares
Common Class A
Ordinary shares
Common Class B
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Private placement
Additional Paid-in Capital
Subscription Receivable
Private placement
Subscription Receivable
Deferred Stock Compensation
Deferred Statutory Reserve
Deficit
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Common Class A
Common Class B
IPO
Private placement
Total
Balance at beginning at Sep. 30, 2024     $ 2,971,181     $ 3,440 $ 500     $ 4,821,992       $ 35,448 $ (1,704,065) $ (186,134) $ 91,074         $ 3,062,255
Balance at beginning (in shares) at Sep. 30, 2024           275,200 40,000                              
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY                                            
Cash proceeds $ 10,350,000     $ 518       $ 10,349,482                       $ 10,350,000    
Cash proceeds (in shares)       41,400                                    
Offering cost deducted to capital     (1,885,650)             (1,885,650)                       (1,885,650)
Non-controlling interest from acquisition     0     $ 0 $ 0     0   $ 0 $ 0 0 0 0 147,907         147,907
Net income (loss)     (4,884,369)                       (4,884,369)   (71,274)         (4,955,643)
Foreign currency translation adjustment     (15,969)                         (15,969) (1)         (15,969)
Balance at end at Mar. 31, 2025     6,535,193     $ 3,958 $ 500     13,285,824       35,448 (6,588,434) (202,103) 167,706         6,702,899
Balance at end (in shares) at Mar. 31, 2025           316,600 40,000                              
Balance at beginning at Sep. 30, 2025     5,781,700     $ 4,622 $ 500     21,960,872     (3,486,439) 35,448 (12,528,647) (204,656) 197,166         5,978,866
Balance at beginning (in shares) at Sep. 30, 2025           369,741 40,000                     316,600 40,000      
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY                                            
Cash proceeds   $ 3,200,000     $ 7,132       $ 8,392,868   $ (5,200,000)                   $ 3,200,000  
Cash proceeds (in shares)         570,540                                  
Offering cost deducted to capital     (480,000)             (480,000)                       (480,000)
Shares issued for partially conversion of convertible note     180,000     $ 205       179,795                       180,000
Shares issued for partially conversion of convertible note (in shares)           16,394                                
Shares issued for compensation     6,984     $ 2,527       2,942,897     (2,938,440)                 6,984
Shares issued for compensation (in shares)           202,183                                
Amortization of deferred stock compensation     1,884,315                   1,884,315                 1,884,315
Net income (loss)     (5,883,478)                       (5,883,478)   (77,811)         (5,961,289)
Foreign currency translation adjustment     (87,249)                         (87,249)           (87,249)
Balance at end at Mar. 31, 2026     $ 4,602,272     $ 14,486 $ 500     $ 32,996,432   $ (5,200,000) $ (4,540,564) $ 35,448 $ (18,412,125) $ (291,905) $ 119,355         $ 4,721,627
Balance at end (in shares) at Mar. 31, 2026           1,158,858 40,000                     1,158,858 40,000     10,000